Company News, Financial News

GSK Rejects Unilever’s Bid for Consumer Healthcare Business

The $68 billion offer included an array of oral care brands including Sensodyne and Aquafresh.

Author Image

By: TOM BRANNA

Editor

GlaxoSmithKline has rejected Unilever's BPS50 billion ($68 billion at current exchange rates) bid for its consumer healthcare business. GSK is ranked No. 12 in Happi's International Top 30. Unilever is ranked No. 1 on the Happi list. Today, Unilever is said to be increasing its offer. GSK is among the global leaders in the oral care sector with brands like Sensodyne, Dr. Best and Aquafresh.  In a statement, GSK said that a series of three bids made by Unilever last year, the last...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters